View Future GrowthCydsa. de 過去の業績過去 基準チェック /56Cydsa. deは、平均年間2.2%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間1.3% 8.5%収益成長率で 成長しています。 Cydsa. deの自己資本利益率は5%であり、純利益率は3.6%です。主要情報2.15%収益成長率2.45%EPS成長率Chemicals 業界の成長13.08%収益成長率8.50%株主資本利益率5.02%ネット・マージン3.59%前回の決算情報31 Mar 2026最近の業績更新分析記事 • May 06Solid Earnings Reflect Cydsa. de's (BMV:CYDSASAA) Strength As A BusinessWhen companies post strong earnings, the stock generally performs well, just like Cydsa, S.A.B. de C.V.'s...Reported Earnings • Mar 02Full year 2025 earnings released: EPS: Mex$1.00 (vs Mex$1.00 in FY 2024)Full year 2025 results: EPS: Mex$1.00. Revenue: Mex$16.3b (up 8.4% from FY 2024). Net income: Mex$532.7m (down 1.0% from FY 2024). Profit margin: 3.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in South America.Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: Mex$0.27 (vs Mex$0.27 in 3Q 2024)Third quarter 2025 results: EPS: Mex$0.27 (in line with 3Q 2024). Revenue: Mex$4.21b (up 7.2% from 3Q 2024). Net income: Mex$145.7m (flat on 3Q 2024). Profit margin: 3.5% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Jul 25Second quarter 2025 earnings released: EPS: Mex$0.12 (vs Mex$0.52 in 2Q 2024)Second quarter 2025 results: EPS: Mex$0.12 (down from Mex$0.52 in 2Q 2024). Revenue: Mex$4.24b (up 11% from 2Q 2024). Net income: Mex$41.1m (down 85% from 2Q 2024). Profit margin: 1.0% (down from 7.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Reported Earnings • Feb 28Full year 2024 earnings releasedFull year 2024 results: Revenue: Mex$15.0b (up 6.2% from FY 2023). Net income: Mex$538.4m (down 74% from FY 2023). Profit margin: 3.6% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: Mex$0.27 (vs Mex$1.06 in 3Q 2023)Third quarter 2024 results: EPS: Mex$0.27 (down from Mex$1.06 in 3Q 2023). Revenue: Mex$3.92b (up 16% from 3Q 2023). Net income: Mex$146.2m (down 75% from 3Q 2023). Profit margin: 3.7% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updates分析記事 • May 06Solid Earnings Reflect Cydsa. de's (BMV:CYDSASAA) Strength As A BusinessWhen companies post strong earnings, the stock generally performs well, just like Cydsa, S.A.B. de C.V.'s...Major Estimate Revision • May 02Consensus EPS estimates increase by 92%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from Mex$17.4b to Mex$16.7b. EPS estimate rose from Mex$1.20 to Mex$2.30. Net income forecast to grow 105% next year vs 34% growth forecast for Chemicals industry in Mexico. Consensus price target up from Mex$52.83 to Mex$54.83. Share price rose 9.5% to Mex$30.00 over the past week.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improves as stock rises 21%After last week's 21% share price gain to Mex$27.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in South America. Total returns to shareholders of 71% over the past three years.Declared Dividend • Mar 30Dividend increased to Mex$0.66Dividend of Mex$0.66 is 0.4% higher than last year. Ex-date: 7th April 2026 Payment date: 8th April 2026 Dividend yield will be 3.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (163% earnings payout ratio). However, it is well covered by cash flows (17% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 81% to bring the payout ratio under control. EPS is expected to grow by 69% over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.お知らせ • Mar 09Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico MexicoNew Risk • Mar 02New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risk Dividend is not well covered by earnings (163% payout ratio).Reported Earnings • Mar 02Full year 2025 earnings released: EPS: Mex$1.00 (vs Mex$1.00 in FY 2024)Full year 2025 results: EPS: Mex$1.00. Revenue: Mex$16.3b (up 8.4% from FY 2024). Net income: Mex$532.7m (down 1.0% from FY 2024). Profit margin: 3.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in South America.Price Target Changed • Mar 01Price target decreased by 8.9% to Mex$52.83Down from Mex$58.00, the current price target is an average from 3 analysts. New target price is 172% above last closing price of Mex$19.40. Stock is up 9.1% over the past year. The company posted earnings per share of Mex$1.00 last year.New Risk • Oct 27New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 88% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (88% net debt to equity). Dividend is not well covered by earnings (163% payout ratio). Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: Mex$0.27 (vs Mex$0.27 in 3Q 2024)Third quarter 2025 results: EPS: Mex$0.27 (in line with 3Q 2024). Revenue: Mex$4.21b (up 7.2% from 3Q 2024). Net income: Mex$145.7m (flat on 3Q 2024). Profit margin: 3.5% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.New Risk • Jul 26New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 89% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (89% net debt to equity). Dividend is not well covered by earnings (152% payout ratio). Profit margins are more than 30% lower than last year (1.3% net profit margin).Reported Earnings • Jul 25Second quarter 2025 earnings released: EPS: Mex$0.12 (vs Mex$0.52 in 2Q 2024)Second quarter 2025 results: EPS: Mex$0.12 (down from Mex$0.52 in 2Q 2024). Revenue: Mex$4.24b (up 11% from 2Q 2024). Net income: Mex$41.1m (down 85% from 2Q 2024). Profit margin: 1.0% (down from 7.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Price Target Changed • Jul 15Price target increased by 12% to Mex$56.50Up from Mex$50.50, the current price target is an average from 2 analysts. New target price is 206% above last closing price of Mex$18.46. Stock is up 5.5% over the past year. The company posted earnings per share of Mex$1.00 last year.分析記事 • May 05Cydsa. de (BMV:CYDSASAA) Has Some Way To Go To Become A Multi-BaggerDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Declared Dividend • Apr 01Dividend increased to Mex$0.66Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years.分析記事 • Mar 30Cydsa. de (BMV:CYDSASAA) Has Announced That It Will Be Increasing Its Dividend To MX$0.6587Cydsa, S.A.B. de C.V.'s ( BMV:CYDSASAA ) periodic dividend will be increasing on the 7th of April to MX$0.6587, with...Declared Dividend • Mar 29Dividend increased to Mex$0.66Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years.お知らせ • Mar 28Cydsa, S.A.B. de C.V. announces Annual dividend, payable on April 07, 2025Cydsa, S.A.B. de C.V. announced Annual dividend of MXN 0.6587 per share payable on April 07, 2025, ex-date on April 04, 2025 and record date on April 04, 2025.New Risk • Mar 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.6% net profit margin).お知らせ • Mar 07Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico MexicoReported Earnings • Feb 28Full year 2024 earnings releasedFull year 2024 results: Revenue: Mex$15.0b (up 6.2% from FY 2023). Net income: Mex$538.4m (down 74% from FY 2023). Profit margin: 3.6% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.New Risk • Oct 25New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.4x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.6% net profit margin).Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: Mex$0.27 (vs Mex$1.06 in 3Q 2023)Third quarter 2024 results: EPS: Mex$0.27 (down from Mex$1.06 in 3Q 2023). Revenue: Mex$3.92b (up 16% from 3Q 2023). Net income: Mex$146.2m (down 75% from 3Q 2023). Profit margin: 3.7% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.New Risk • Jul 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 17% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Reported Earnings • Jul 24Second quarter 2024 earnings released: EPS: Mex$0.52 (vs Mex$1.00 in 2Q 2023)Second quarter 2024 results: EPS: Mex$0.52 (down from Mex$1.00 in 2Q 2023). Revenue: Mex$3.83b (up 15% from 2Q 2023). Net income: Mex$276.6m (down 50% from 2Q 2023). Profit margin: 7.2% (down from 17% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.New Risk • Apr 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Reported Earnings • Apr 25First quarter 2024 earnings released: EPS: Mex$0.39 (vs Mex$0.85 in 1Q 2023)First quarter 2024 results: EPS: Mex$0.39 (down from Mex$0.85 in 1Q 2023). Revenue: Mex$3.13b (down 15% from 1Q 2023). Net income: Mex$212.6m (down 54% from 1Q 2023). Profit margin: 6.8% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 23Full year 2023 earnings released: EPS: Mex$3.83 (vs Mex$2.24 in FY 2022)Full year 2023 results: EPS: Mex$3.83 (up from Mex$2.24 in FY 2022). Revenue: Mex$14.2b (up 4.0% from FY 2022). Net income: Mex$2.07b (up 70% from FY 2022). Profit margin: 15% (up from 9.0% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Global Chemicals industry. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.New Risk • Oct 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Reported Earnings • Oct 26Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: Mex$3.38b (down 4.9% from 3Q 2022). Net income: Mex$581.2m (up 161% from 3Q 2022). Profit margin: 17% (up from 6.3% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in South America.Reported Earnings • Jul 26Second quarter 2023 earnings released: EPS: Mex$1.00 (vs Mex$0.45 in 2Q 2022)Second quarter 2023 results: EPS: Mex$1.00 (up from Mex$0.45 in 2Q 2022). Revenue: Mex$3.33b (flat on 2Q 2022). Net income: Mex$547.5m (up 120% from 2Q 2022). Profit margin: 17% (up from 7.4% in 2Q 2022). Revenue is forecast to grow 10.0% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (94% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.6% average weekly change).分析記事 • May 06Returns Are Gaining Momentum At Cydsa. de (BMV:CYDSASAA)To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: Mex$0.85 (vs Mex$0.38 in 1Q 2022)First quarter 2023 results: EPS: Mex$0.85 (up from Mex$0.38 in 1Q 2022). Revenue: Mex$3.67b (up 20% from 1Q 2022). Net income: Mex$461.0m (up 116% from 1Q 2022). Profit margin: 13% (up from 7.0% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • Apr 03Upcoming dividend of Mex$0.46 per share at 2.1% yieldEligible shareholders must have bought the stock before 10 April 2023. Payment date: 12 April 2023. Payout ratio is a comfortable 19% but the company is paying out more than the cash it is generating. Trailing yield: 2.1%. Lower than top quartile of Mexican dividend payers (6.1%). Lower than average of industry peers (15%).Price Target Changed • Feb 27Price target increased by 16% to Mex$42.90Up from Mex$37.00, the current price target is an average from 3 analysts. New target price is 150% above last closing price of Mex$17.15. Stock is up 29% over the past year. The company posted earnings per share of Mex$2.23 last year.Reported Earnings • Feb 24Full year 2022 earnings released: EPS: Mex$2.23 (vs Mex$1.00 in FY 2021)Full year 2022 results: EPS: Mex$2.23 (up from Mex$1.00 in FY 2021). Revenue: Mex$13.6b (up 20% from FY 2021). Net income: Mex$1.22b (up 119% from FY 2021). Profit margin: 9.0% (up from 4.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 2.0% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 11% per year.分析記事 • Jan 18The Returns At Cydsa. de (BMV:CYDSASAA) Aren't GrowingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Price Target Changed • Nov 16Price target decreased to Mex$32.23Down from Mex$37.00, the current price target is an average from 3 analysts. New target price is 148% above last closing price of Mex$13.00. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year.Reported Earnings • Oct 26Third quarter 2022 earnings released: EPS: Mex$0.41 (vs Mex$0.19 in 3Q 2021)Third quarter 2022 results: EPS: Mex$0.41 (up from Mex$0.19 in 3Q 2021). Revenue: Mex$3.55b (up 26% from 3Q 2021). Net income: Mex$222.6m (up 101% from 3Q 2021). Profit margin: 6.3% (up from 4.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 1.8% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 19% per year.Price Target Changed • Sep 30Price target decreased to Mex$33.90Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 161% above last closing price of Mex$13.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year.Reported Earnings • Jul 27Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: Mex$3.36b (up 18% from 2Q 2021). Net income: Mex$248.0m (up Mex$215.9m from 2Q 2021). Profit margin: 7.4% (up from 1.1% in 2Q 2021). The increase in margin was driven by higher revenue.Reported Earnings • May 01First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: Mex$0.38 (up from Mex$0.13 in 1Q 2021). Revenue: Mex$3.06b (up 18% from 1Q 2021). Net income: Mex$213.4m (up 182% from 1Q 2021). Profit margin: 7.0% (up from 2.9% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.Price Target Changed • Apr 27Price target decreased to Mex$33.77Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 150% above last closing price of Mex$13.50. Stock is down 4.1% over the past year. The company is forecast to post earnings per share of Mex$1.50 for next year compared to Mex$1.00 last year.Reported Earnings • Feb 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: Mex$1.00 (up from Mex$0.92 in FY 2020). Revenue: Mex$11.3b (up 5.7% from FY 2020). Net income: Mex$557.0m (up 9.0% from FY 2020). Profit margin: 4.9% (up from 4.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 23%. Over the next year, revenue is forecast to grow 3.0%, compared to a 4.6% growth forecast for the industry in Mexico. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to Mex$14.93, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry globally. Total loss to shareholders of 50% over the past three years.Price Target Changed • Oct 30Price target decreased to Mex$33.77Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 145% above last closing price of Mex$13.80. Stock is down 34% over the past year. The company is forecast to post earnings per share of Mex$0.80 for next year compared to Mex$0.92 last year.Reported Earnings • Oct 29Third quarter 2021 earnings released: EPS Mex$0.19 (vs Mex$0.11 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: Mex$2.81b (down 1.7% from 3Q 2020). Net income: Mex$110.9m (up Mex$174.5m from 3Q 2020). Profit margin: 4.0% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 24% per year.分析記事 • May 25Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares Could Be 40% Below Their Intrinsic Value EstimateDoes the May share price for Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) reflect what it's really worth? Today, we will...分析記事 • Apr 16Here's Why Cydsa. de (BMV:CYDSASAA) Is Weighed Down By Its Debt LoadDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Upcoming Dividend • Mar 30Upcoming dividend of Mex$0.36 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 2.4%. Lower than top quartile of Mexican dividend payers (4.9%). Lower than average of industry peers (4.1%).Reported Earnings • Mar 28Full year 2020 earnings released: EPS Mex$0.92 (vs Mex$2.24 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: Mex$10.7b (up 2.1% from FY 2019). Net income: Mex$511.0m (down 60% from FY 2019). Profit margin: 4.8% (down from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.分析記事 • Mar 07We Think That There Are More Issues For Cydsa. de (BMV:CYDSASAA) Than Just Sluggish EarningsCydsa, S.A.B. de C.V.'s ( BMV:CYDSASAA ) recent weak earnings report didn't cause a big stock movement. We think that...分析記事 • Mar 05Do Institutions Own Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares?Every investor in Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) should be aware of the most powerful shareholder groups...Is New 90 Day High Low • Feb 25New 90-day low: Mex$17.40The company is down 19% from its price of Mex$21.50 on 25 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.分析記事 • Feb 10Is Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) A Good Fit For Your Dividend Portfolio?Is Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) a good dividend stock? How can we tell? Dividend paying companies with...分析記事 • Jan 26Cydsa. de's(BMV:CYDSASAA) Share Price Is Down 43% Over The Past Three Years.As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...Is New 90 Day High Low • Jan 26New 90-day low: Mex$17.99The company is down 14% from its price of Mex$21.00 on 26 October 2020. The Mexican market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.分析記事 • Jan 13What We Make Of Cydsa. de's (BMV:CYDSASAA) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...Is New 90 Day High Low • Jan 11New 90-day low: Mex$19.87The company is down 1.0% from its price of Mex$20.00 on 13 October 2020. The Mexican market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period.分析記事 • Dec 31Is Cydsa. de (BMV:CYDSASAA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Dec 18Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Has A ROE Of 9.8%Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...分析記事 • Dec 05What Type Of Shareholders Own The Most Number of Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares?If you want to know who really controls Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ), then you'll have to look at the makeup...分析記事 • Nov 22Calculating The Intrinsic Value Of Cydsa, S.A.B. de C.V. (BMV:CYDSASAA)How far off is Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) from its intrinsic value? Using the most recent financial data...お知らせ • Sep 25Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner purchased certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V.Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner, it has completed the purchase of certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V. Bemis owns 51 percent of the acquired business. Specific terms of the acquisition were not disclosed. Recently reported annual sales related to the assets to be acquired were approximately $35 million. Fredericks Michael & Co. acted as the financial advisor to Cydsa. Bemis Company, Inc., completed the acquisition of Masterpak S.A. de C.V., on May 26, 2004.収支内訳Cydsa. de の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BMV:CYDSASA A 収益、費用、利益 ( )MXN Millions日付収益収益G+A経費研究開発費31 Mar 2616,2555834,442031 Dec 2516,2995324,361030 Sep 2516,5572164,165030 Jun 2516,2732163,735031 Mar 2515,8674523,704031 Dec 2415,0395383,617030 Sep 2414,6751,1193,503030 Jun 2414,1271,5543,559031 Mar 2413,6201,8253,338031 Dec 2314,1602,0733,203030 Sep 2314,0222,1273,103030 Jun 2314,1951,7693,059031 Mar 2314,2261,4702,997031 Dec 2213,6121,2222,930030 Sep 2213,0691,0232,790030 Jun 2212,3289112,731031 Mar 2211,8076952,663031 Dec 2111,3395572,565030 Sep 2110,9772422,518030 Jun 2111,027672,428031 Mar 2110,7702642,393031 Dec 2010,7264482,337030 Sep 2010,4221,0002,312030 Jun 2010,3301,3242,274031 Mar 2010,5621,3482,213031 Dec 1910,5071,1882,155030 Sep 1910,6228332,159030 Jun 1910,6418402,123031 Mar 1910,6818532,073031 Dec 1810,6088242,057030 Sep 1810,4126251,918030 Jun 189,8716191,852031 Mar 189,3805801,793031 Dec 179,1185271,721030 Sep 178,6147481,712030 Jun 178,2266421,633031 Mar 177,6354461,528031 Dec 166,9585001,440030 Sep 166,4855451,462030 Jun 166,0693041,412031 Mar 165,7283841,396031 Dec 155,5693361,391030 Sep 155,570631,328030 Jun 155,4812581,2890質の高い収益: CYDSASA Aは 高品質の収益 を持っています。利益率の向上: CYDSASA Aの現在の純利益率 (3.6%)は、昨年(2.8%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CYDSASA Aの収益は過去 5 年間で年間2.2%増加しました。成長の加速: CYDSASA Aの過去 1 年間の収益成長率 ( 29.1% ) は、5 年間の平均 ( 年間2.2%を上回っています。収益対業界: CYDSASA Aの過去 1 年間の収益成長率 ( 29.1% ) はChemicals業界-11.3%を上回りました。株主資本利益率高いROE: CYDSASA Aの 自己資本利益率 ( 5% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/28 16:29終値2026/05/27 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cydsa, S.A.B. de C.V. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Carlos Alcaraz PinedaApalache AnálisisAlejandro Azar WabiGBM Grupo Bursátil Mexicano, S.A. de C.V. Casa de BolsaRegina Carrillo VillasanaGBM Grupo Bursátil Mexicano, S.A. de C.V. Casa de Bolsa1 その他のアナリストを表示
分析記事 • May 06Solid Earnings Reflect Cydsa. de's (BMV:CYDSASAA) Strength As A BusinessWhen companies post strong earnings, the stock generally performs well, just like Cydsa, S.A.B. de C.V.'s...
Reported Earnings • Mar 02Full year 2025 earnings released: EPS: Mex$1.00 (vs Mex$1.00 in FY 2024)Full year 2025 results: EPS: Mex$1.00. Revenue: Mex$16.3b (up 8.4% from FY 2024). Net income: Mex$532.7m (down 1.0% from FY 2024). Profit margin: 3.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in South America.
Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: Mex$0.27 (vs Mex$0.27 in 3Q 2024)Third quarter 2025 results: EPS: Mex$0.27 (in line with 3Q 2024). Revenue: Mex$4.21b (up 7.2% from 3Q 2024). Net income: Mex$145.7m (flat on 3Q 2024). Profit margin: 3.5% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Jul 25Second quarter 2025 earnings released: EPS: Mex$0.12 (vs Mex$0.52 in 2Q 2024)Second quarter 2025 results: EPS: Mex$0.12 (down from Mex$0.52 in 2Q 2024). Revenue: Mex$4.24b (up 11% from 2Q 2024). Net income: Mex$41.1m (down 85% from 2Q 2024). Profit margin: 1.0% (down from 7.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 28Full year 2024 earnings releasedFull year 2024 results: Revenue: Mex$15.0b (up 6.2% from FY 2023). Net income: Mex$538.4m (down 74% from FY 2023). Profit margin: 3.6% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: Mex$0.27 (vs Mex$1.06 in 3Q 2023)Third quarter 2024 results: EPS: Mex$0.27 (down from Mex$1.06 in 3Q 2023). Revenue: Mex$3.92b (up 16% from 3Q 2023). Net income: Mex$146.2m (down 75% from 3Q 2023). Profit margin: 3.7% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
分析記事 • May 06Solid Earnings Reflect Cydsa. de's (BMV:CYDSASAA) Strength As A BusinessWhen companies post strong earnings, the stock generally performs well, just like Cydsa, S.A.B. de C.V.'s...
Major Estimate Revision • May 02Consensus EPS estimates increase by 92%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from Mex$17.4b to Mex$16.7b. EPS estimate rose from Mex$1.20 to Mex$2.30. Net income forecast to grow 105% next year vs 34% growth forecast for Chemicals industry in Mexico. Consensus price target up from Mex$52.83 to Mex$54.83. Share price rose 9.5% to Mex$30.00 over the past week.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improves as stock rises 21%After last week's 21% share price gain to Mex$27.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in South America. Total returns to shareholders of 71% over the past three years.
Declared Dividend • Mar 30Dividend increased to Mex$0.66Dividend of Mex$0.66 is 0.4% higher than last year. Ex-date: 7th April 2026 Payment date: 8th April 2026 Dividend yield will be 3.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (163% earnings payout ratio). However, it is well covered by cash flows (17% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 81% to bring the payout ratio under control. EPS is expected to grow by 69% over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
お知らせ • Mar 09Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico Mexico
New Risk • Mar 02New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risk Dividend is not well covered by earnings (163% payout ratio).
Reported Earnings • Mar 02Full year 2025 earnings released: EPS: Mex$1.00 (vs Mex$1.00 in FY 2024)Full year 2025 results: EPS: Mex$1.00. Revenue: Mex$16.3b (up 8.4% from FY 2024). Net income: Mex$532.7m (down 1.0% from FY 2024). Profit margin: 3.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in South America.
Price Target Changed • Mar 01Price target decreased by 8.9% to Mex$52.83Down from Mex$58.00, the current price target is an average from 3 analysts. New target price is 172% above last closing price of Mex$19.40. Stock is up 9.1% over the past year. The company posted earnings per share of Mex$1.00 last year.
New Risk • Oct 27New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 88% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (88% net debt to equity). Dividend is not well covered by earnings (163% payout ratio). Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).
Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: Mex$0.27 (vs Mex$0.27 in 3Q 2024)Third quarter 2025 results: EPS: Mex$0.27 (in line with 3Q 2024). Revenue: Mex$4.21b (up 7.2% from 3Q 2024). Net income: Mex$145.7m (flat on 3Q 2024). Profit margin: 3.5% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
New Risk • Jul 26New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 89% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (89% net debt to equity). Dividend is not well covered by earnings (152% payout ratio). Profit margins are more than 30% lower than last year (1.3% net profit margin).
Reported Earnings • Jul 25Second quarter 2025 earnings released: EPS: Mex$0.12 (vs Mex$0.52 in 2Q 2024)Second quarter 2025 results: EPS: Mex$0.12 (down from Mex$0.52 in 2Q 2024). Revenue: Mex$4.24b (up 11% from 2Q 2024). Net income: Mex$41.1m (down 85% from 2Q 2024). Profit margin: 1.0% (down from 7.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Price Target Changed • Jul 15Price target increased by 12% to Mex$56.50Up from Mex$50.50, the current price target is an average from 2 analysts. New target price is 206% above last closing price of Mex$18.46. Stock is up 5.5% over the past year. The company posted earnings per share of Mex$1.00 last year.
分析記事 • May 05Cydsa. de (BMV:CYDSASAA) Has Some Way To Go To Become A Multi-BaggerDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Declared Dividend • Apr 01Dividend increased to Mex$0.66Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years.
分析記事 • Mar 30Cydsa. de (BMV:CYDSASAA) Has Announced That It Will Be Increasing Its Dividend To MX$0.6587Cydsa, S.A.B. de C.V.'s ( BMV:CYDSASAA ) periodic dividend will be increasing on the 7th of April to MX$0.6587, with...
Declared Dividend • Mar 29Dividend increased to Mex$0.66Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years.
お知らせ • Mar 28Cydsa, S.A.B. de C.V. announces Annual dividend, payable on April 07, 2025Cydsa, S.A.B. de C.V. announced Annual dividend of MXN 0.6587 per share payable on April 07, 2025, ex-date on April 04, 2025 and record date on April 04, 2025.
New Risk • Mar 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.6% net profit margin).
お知らせ • Mar 07Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico Mexico
Reported Earnings • Feb 28Full year 2024 earnings releasedFull year 2024 results: Revenue: Mex$15.0b (up 6.2% from FY 2023). Net income: Mex$538.4m (down 74% from FY 2023). Profit margin: 3.6% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 25New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.4x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.6% net profit margin).
Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: Mex$0.27 (vs Mex$1.06 in 3Q 2023)Third quarter 2024 results: EPS: Mex$0.27 (down from Mex$1.06 in 3Q 2023). Revenue: Mex$3.92b (up 16% from 3Q 2023). Net income: Mex$146.2m (down 75% from 3Q 2023). Profit margin: 3.7% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 17% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Reported Earnings • Jul 24Second quarter 2024 earnings released: EPS: Mex$0.52 (vs Mex$1.00 in 2Q 2023)Second quarter 2024 results: EPS: Mex$0.52 (down from Mex$1.00 in 2Q 2023). Revenue: Mex$3.83b (up 15% from 2Q 2023). Net income: Mex$276.6m (down 50% from 2Q 2023). Profit margin: 7.2% (down from 17% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
New Risk • Apr 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Reported Earnings • Apr 25First quarter 2024 earnings released: EPS: Mex$0.39 (vs Mex$0.85 in 1Q 2023)First quarter 2024 results: EPS: Mex$0.39 (down from Mex$0.85 in 1Q 2023). Revenue: Mex$3.13b (down 15% from 1Q 2023). Net income: Mex$212.6m (down 54% from 1Q 2023). Profit margin: 6.8% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 23Full year 2023 earnings released: EPS: Mex$3.83 (vs Mex$2.24 in FY 2022)Full year 2023 results: EPS: Mex$3.83 (up from Mex$2.24 in FY 2022). Revenue: Mex$14.2b (up 4.0% from FY 2022). Net income: Mex$2.07b (up 70% from FY 2022). Profit margin: 15% (up from 9.0% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Global Chemicals industry. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Reported Earnings • Oct 26Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: Mex$3.38b (down 4.9% from 3Q 2022). Net income: Mex$581.2m (up 161% from 3Q 2022). Profit margin: 17% (up from 6.3% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in South America.
Reported Earnings • Jul 26Second quarter 2023 earnings released: EPS: Mex$1.00 (vs Mex$0.45 in 2Q 2022)Second quarter 2023 results: EPS: Mex$1.00 (up from Mex$0.45 in 2Q 2022). Revenue: Mex$3.33b (flat on 2Q 2022). Net income: Mex$547.5m (up 120% from 2Q 2022). Profit margin: 17% (up from 7.4% in 2Q 2022). Revenue is forecast to grow 10.0% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (94% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.6% average weekly change).
分析記事 • May 06Returns Are Gaining Momentum At Cydsa. de (BMV:CYDSASAA)To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: Mex$0.85 (vs Mex$0.38 in 1Q 2022)First quarter 2023 results: EPS: Mex$0.85 (up from Mex$0.38 in 1Q 2022). Revenue: Mex$3.67b (up 20% from 1Q 2022). Net income: Mex$461.0m (up 116% from 1Q 2022). Profit margin: 13% (up from 7.0% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 03Upcoming dividend of Mex$0.46 per share at 2.1% yieldEligible shareholders must have bought the stock before 10 April 2023. Payment date: 12 April 2023. Payout ratio is a comfortable 19% but the company is paying out more than the cash it is generating. Trailing yield: 2.1%. Lower than top quartile of Mexican dividend payers (6.1%). Lower than average of industry peers (15%).
Price Target Changed • Feb 27Price target increased by 16% to Mex$42.90Up from Mex$37.00, the current price target is an average from 3 analysts. New target price is 150% above last closing price of Mex$17.15. Stock is up 29% over the past year. The company posted earnings per share of Mex$2.23 last year.
Reported Earnings • Feb 24Full year 2022 earnings released: EPS: Mex$2.23 (vs Mex$1.00 in FY 2021)Full year 2022 results: EPS: Mex$2.23 (up from Mex$1.00 in FY 2021). Revenue: Mex$13.6b (up 20% from FY 2021). Net income: Mex$1.22b (up 119% from FY 2021). Profit margin: 9.0% (up from 4.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 2.0% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 11% per year.
分析記事 • Jan 18The Returns At Cydsa. de (BMV:CYDSASAA) Aren't GrowingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Price Target Changed • Nov 16Price target decreased to Mex$32.23Down from Mex$37.00, the current price target is an average from 3 analysts. New target price is 148% above last closing price of Mex$13.00. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year.
Reported Earnings • Oct 26Third quarter 2022 earnings released: EPS: Mex$0.41 (vs Mex$0.19 in 3Q 2021)Third quarter 2022 results: EPS: Mex$0.41 (up from Mex$0.19 in 3Q 2021). Revenue: Mex$3.55b (up 26% from 3Q 2021). Net income: Mex$222.6m (up 101% from 3Q 2021). Profit margin: 6.3% (up from 4.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 1.8% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 19% per year.
Price Target Changed • Sep 30Price target decreased to Mex$33.90Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 161% above last closing price of Mex$13.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year.
Reported Earnings • Jul 27Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: Mex$3.36b (up 18% from 2Q 2021). Net income: Mex$248.0m (up Mex$215.9m from 2Q 2021). Profit margin: 7.4% (up from 1.1% in 2Q 2021). The increase in margin was driven by higher revenue.
Reported Earnings • May 01First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: Mex$0.38 (up from Mex$0.13 in 1Q 2021). Revenue: Mex$3.06b (up 18% from 1Q 2021). Net income: Mex$213.4m (up 182% from 1Q 2021). Profit margin: 7.0% (up from 2.9% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
Price Target Changed • Apr 27Price target decreased to Mex$33.77Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 150% above last closing price of Mex$13.50. Stock is down 4.1% over the past year. The company is forecast to post earnings per share of Mex$1.50 for next year compared to Mex$1.00 last year.
Reported Earnings • Feb 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: Mex$1.00 (up from Mex$0.92 in FY 2020). Revenue: Mex$11.3b (up 5.7% from FY 2020). Net income: Mex$557.0m (up 9.0% from FY 2020). Profit margin: 4.9% (up from 4.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 23%. Over the next year, revenue is forecast to grow 3.0%, compared to a 4.6% growth forecast for the industry in Mexico. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to Mex$14.93, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry globally. Total loss to shareholders of 50% over the past three years.
Price Target Changed • Oct 30Price target decreased to Mex$33.77Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 145% above last closing price of Mex$13.80. Stock is down 34% over the past year. The company is forecast to post earnings per share of Mex$0.80 for next year compared to Mex$0.92 last year.
Reported Earnings • Oct 29Third quarter 2021 earnings released: EPS Mex$0.19 (vs Mex$0.11 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: Mex$2.81b (down 1.7% from 3Q 2020). Net income: Mex$110.9m (up Mex$174.5m from 3Q 2020). Profit margin: 4.0% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 24% per year.
分析記事 • May 25Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares Could Be 40% Below Their Intrinsic Value EstimateDoes the May share price for Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) reflect what it's really worth? Today, we will...
分析記事 • Apr 16Here's Why Cydsa. de (BMV:CYDSASAA) Is Weighed Down By Its Debt LoadDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Upcoming Dividend • Mar 30Upcoming dividend of Mex$0.36 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 2.4%. Lower than top quartile of Mexican dividend payers (4.9%). Lower than average of industry peers (4.1%).
Reported Earnings • Mar 28Full year 2020 earnings released: EPS Mex$0.92 (vs Mex$2.24 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: Mex$10.7b (up 2.1% from FY 2019). Net income: Mex$511.0m (down 60% from FY 2019). Profit margin: 4.8% (down from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
分析記事 • Mar 07We Think That There Are More Issues For Cydsa. de (BMV:CYDSASAA) Than Just Sluggish EarningsCydsa, S.A.B. de C.V.'s ( BMV:CYDSASAA ) recent weak earnings report didn't cause a big stock movement. We think that...
分析記事 • Mar 05Do Institutions Own Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares?Every investor in Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) should be aware of the most powerful shareholder groups...
Is New 90 Day High Low • Feb 25New 90-day low: Mex$17.40The company is down 19% from its price of Mex$21.50 on 25 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
分析記事 • Feb 10Is Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) A Good Fit For Your Dividend Portfolio?Is Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ) a good dividend stock? How can we tell? Dividend paying companies with...
分析記事 • Jan 26Cydsa. de's(BMV:CYDSASAA) Share Price Is Down 43% Over The Past Three Years.As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...
Is New 90 Day High Low • Jan 26New 90-day low: Mex$17.99The company is down 14% from its price of Mex$21.00 on 26 October 2020. The Mexican market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
分析記事 • Jan 13What We Make Of Cydsa. de's (BMV:CYDSASAA) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
Is New 90 Day High Low • Jan 11New 90-day low: Mex$19.87The company is down 1.0% from its price of Mex$20.00 on 13 October 2020. The Mexican market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period.
分析記事 • Dec 31Is Cydsa. de (BMV:CYDSASAA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Dec 18Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Has A ROE Of 9.8%Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
分析記事 • Dec 05What Type Of Shareholders Own The Most Number of Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) Shares?If you want to know who really controls Cydsa, S.A.B. de C.V. ( BMV:CYDSASAA ), then you'll have to look at the makeup...
分析記事 • Nov 22Calculating The Intrinsic Value Of Cydsa, S.A.B. de C.V. (BMV:CYDSASAA)How far off is Cydsa, S.A.B. de C.V. (BMV:CYDSASAA) from its intrinsic value? Using the most recent financial data...
お知らせ • Sep 25Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner purchased certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V.Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner, it has completed the purchase of certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V. Bemis owns 51 percent of the acquired business. Specific terms of the acquisition were not disclosed. Recently reported annual sales related to the assets to be acquired were approximately $35 million. Fredericks Michael & Co. acted as the financial advisor to Cydsa. Bemis Company, Inc., completed the acquisition of Masterpak S.A. de C.V., on May 26, 2004.